title: Quality of life survey and palliative care in lung cancer patients.
abstract: Aim. In patients with advanced and/or inoperable bronchial tumors, methods of palliative care such as radiotherapy, chemotherapy, brachytherapy and cryotherapy, singly and/or in combination, aiming at extending the survival time and improving the quality of life, were examined. Methods. One hundred and sixty three (163) patients, with mean age 67.9 yrs (range 22-25) and a male/female ratio at 1.34/1, treated between 2000-2004 were studied. Eighty one (81) patients receiving only cryotherapy presented a two-year survival rate at 19.3%, whilst eighty three (83) patients treated with radiotherapy or brachytherapy and/or chemotherapy showed a two-year survival rate at 25%. Sixty-five percent (65%) of patients only cryotreated had improvement in at least one or more Karnofsky and WHO indices. Results. Eighty percent (80%) of patients who received cryotherapy accompanied with supplementary palliative treatment showed amelioration of their clinical status. Conclusion. It seems that for patients with advanced or inoperable lung tumors, cryotherapy associated with additional palliative care may influence the survival time and improve their quality of life.
authors.forename: L
authors.initials: L
authors.lastname: Zoganas
authors.forename: G
authors.initials: G
authors.lastname: Bablekos
authors.forename: M
authors.initials: M
authors.lastname: Maiwand
authors.forename: A
authors.initials: A
authors.lastname: Charalabopoulos
authors.forename: V
authors.initials: V
authors.lastname: Andronadi
authors.forename: A
authors.initials: A
authors.lastname: Batistatou
authors.forename: G
authors.initials: G
authors.lastname: Vergoulas
authors.forename: K
authors.initials: K
authors.lastname: Charalabopoulos
references.citation: Cryobiology. 2005 Feb;50(1):29-37
references.pmid: 15710367
references.citation: Acta Clin Belg. 2001 Mar-Apr;56(2):73-7
references.pmid: 11383315
references.citation: Acta Oncol. 1989;28(1):29-33
references.pmid: 2539845
references.citation: Am J Surg. 1985 Jul;150(1):71-7
references.pmid: 2409829
references.citation: Int J Radiat Oncol Biol Phys. 1992;24(3):551-3
references.pmid: 1383178
references.citation: Ann Oncol. 2002;13 Suppl 4:247-50
references.pmid: 12401697
references.citation: Schweiz Med Wochenschr. 1995 May 27;125(21):1052-9
references.pmid: 7539548
references.citation: Chest. 1996 Sep;110(3):718-23
references.pmid: 8797417
references.citation: Med J Aust. 1987 Oct 19;147(8):391-4
references.pmid: 2443823
references.citation: Pathol Biol (Paris). 2005 May;53(4):199-203
references.pmid: 15850952
references.citation: Thorax. 1987 Jul;42(7):511-5
references.pmid: 2449742
references.citation: Clin Chest Med. 1999 Mar;20(1):123-38
references.pmid: 10205722
references.citation: Lung Cancer. 2004 Aug;45 Suppl 2:S235-8
references.pmid: 15552804
references.citation: Int J Radiat Oncol Biol Phys. 1986 Feb;12(2):231-2
references.pmid: 3005200
references.citation: Cancer. 1995 May 1;75(9):2345-50
references.pmid: 7712446
references.citation: Med J Aust. 1997 Jun 2;166(S1):S17-20
references.pmid: 9201200
references.citation: Radiology. 1979 Jul;132(1):175-6
references.pmid: 109898
references.citation: Radiology. 2005 Apr;235(1):289-98
references.pmid: 15798173
references.citation: Clin Radiol. 1988 May;39(3):284-6
references.pmid: 2456177
references.citation: Hematol Oncol Clin North Am. 1990 Dec;4(6):1169-81
references.pmid: 1704880
references.citation: Clin Chest Med. 1995 Sep;16(3):427-43
references.pmid: 8521698
references.citation: J Clin Oncol. 1991 Jul;9(7):1157-62
references.pmid: 1646292
references.citation: Chest. 2003 Jan;123(1 Suppl):176S-180S
references.pmid: 12527577